{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-004976","form_type":"8-K","ticker":"QTTB","cik":"0001661998","company_name":"Q32 Bio Inc.","filed_at":"2025-01-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.353038+00:00","generated_at":"2026-05-28T03:31:04.334528+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Q32 Bio updates corporate presentation for investor meetings; no financial details given","bullets":["Presentation updated as of January 13, 2025, available on company website.","Overview covers immune therapeutics pipeline but no new financial or strategic data disclosed.","No material changes to guidance, pipeline, or leadership reported in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-004976","json":"https://secwatch.observer/filing/0001193125-25-004976.json","markdown":"https://secwatch.observer/filing/0001193125-25-004976.md","text":"https://secwatch.observer/filing/0001193125-25-004976.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661998/000119312525004976/0001193125-25-004976-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661998/000119312525004976/d753173d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T03:31:04.334528+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}